Skip to main content
Erschienen in: Journal of Cachexia, Sarcopenia and Muscle 3/2013

01.09.2013 | Original Article

Association of a 7-year percent change in fat mass and muscle mass with subsequent cognitive dysfunction: the EPIDOS-Toulouse cohort

verfasst von: Gabor Abellan van Kan, Matteo Cesari, Sophie Gillette-Guyonnet, Charlotte Dupuy, Bruno Vellas, Yves Rolland

Erschienen in: Journal of Cachexia, Sarcopenia and Muscle | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Cognitive dysfunction and changes in body composition share common pathophysiological pathways. The aim of the present paper was to evaluate whether changes in appendicular muscle mass (AMM) and fat mass (FM) are associated factors with an increased risk of cognitive dysfunction in community-dwelling older women.

Methods

A nested case–control study was performed in 181 women aged 75 years and older from a subsample of the Epidemiologie de l'Osteoporose participants from Toulouse. Body composition parameters at inclusion and 7 years later (assessed by dual energy X-ray absorptiometry), and the presence of cognitive dysfunction (dementia and mild cognitive impairment) at 7 years of follow-up, assured by two memory experts based on best clinical practice and validated criteria, were obtained. Multivariate logistic regression models assessed the association of percent change in AMM and FM with risk of cognitive dysfunction.

Results

At 7 years of follow-up, 15 participants suffered from dementia, 6 suffered from mild cognitive impairment, and 160 were cognitively normal. Neither body composition changes nor gait speed was found to be statistically associated with cognitive dysfunction after controlling for potential confounders. Only age, over 85 years, was associated with an increased risk of subsequent cognitive impairment (odds ratio 3.10; 95 % confidence interval 1.07–8.87).

Conclusions

No significant association could be evidenced between changes in body composition and cognitive dysfunction. Due to the small sample size, statistical power could be an issue. The study could also suggest the possibility that the risk of cognitive dysfunction is not mediated by changes in body composition.
Literatur
1.
Zurück zum Zitat Burns JM, Johnson DK, Watts A, et al. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol. 2010;67:428–33.PubMedCrossRef Burns JM, Johnson DK, Watts A, et al. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol. 2010;67:428–33.PubMedCrossRef
2.
Zurück zum Zitat Nourhashémi F, Andrieu S, Gillette-Guyonnet S, et al. Is there a relationship between fat-free soft tissue mass and low cognitive function? Results from a study of 7,105 women. J Am Geriatr Soc. 2002;50:1796–801.PubMedCrossRef Nourhashémi F, Andrieu S, Gillette-Guyonnet S, et al. Is there a relationship between fat-free soft tissue mass and low cognitive function? Results from a study of 7,105 women. J Am Geriatr Soc. 2002;50:1796–801.PubMedCrossRef
3.
Zurück zum Zitat Auyeung TW, Kwok T, Lee J, Leung PC, Leung J, Woo J. Functional decline in cognitive impairment—the relationship between physical and cognitive function. Neuroepidemiology. 2008;31:167–73.PubMedCrossRef Auyeung TW, Kwok T, Lee J, Leung PC, Leung J, Woo J. Functional decline in cognitive impairment—the relationship between physical and cognitive function. Neuroepidemiology. 2008;31:167–73.PubMedCrossRef
4.
Zurück zum Zitat Abellan van Kan G, Rolland Y, Gillette-Guyonnet S. Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort. J Gerontol A Biol Sci Med Sci. 2012;67:425–32.PubMedCrossRef Abellan van Kan G, Rolland Y, Gillette-Guyonnet S. Gait speed, body composition, and dementia. The EPIDOS-Toulouse cohort. J Gerontol A Biol Sci Med Sci. 2012;67:425–32.PubMedCrossRef
5.
Zurück zum Zitat Wirth R, Smoliner C, Sieber CC, Volkert D. Cognitive function is associated with body composition and nutritional risk of geriatric patients. J Nutr Health Aging. 2011;15:706–10.PubMedCrossRef Wirth R, Smoliner C, Sieber CC, Volkert D. Cognitive function is associated with body composition and nutritional risk of geriatric patients. J Nutr Health Aging. 2011;15:706–10.PubMedCrossRef
6.
Zurück zum Zitat Abellan van Kan G, Cesari M, Dupuy C. Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing. 2013;42:196–202.PubMedCrossRef Abellan van Kan G, Cesari M, Dupuy C. Sarcopenia and cognitive impairment in elderly women: results from the EPIDOS cohort. Age Ageing. 2013;42:196–202.PubMedCrossRef
7.
Zurück zum Zitat Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119:526–e9–17.PubMedCrossRef Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119:526–e9–17.PubMedCrossRef
8.
Zurück zum Zitat Gillette Guyonet S, Abellan van Kan G, Alix E. IANA (International Academy on Nutrition and Aging) expert group: weight loss and Alzheimer's disease. J Nutr Health Aging. 2007;11:38–48. Gillette Guyonet S, Abellan van Kan G, Alix E. IANA (International Academy on Nutrition and Aging) expert group: weight loss and Alzheimer's disease. J Nutr Health Aging. 2007;11:38–48.
9.
Zurück zum Zitat Dargent-Molina P, Favier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996;348:145–9.PubMedCrossRef Dargent-Molina P, Favier F, Grandjean H, et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996;348:145–9.PubMedCrossRef
10.
Zurück zum Zitat Andrieu S, Gillette S, Amouyal K, et al. Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study. J Gerontol A Biol Sci Med Sci. 2003;58:372–7.PubMedCrossRef Andrieu S, Gillette S, Amouyal K, et al. Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study. J Gerontol A Biol Sci Med Sci. 2003;58:372–7.PubMedCrossRef
11.
Zurück zum Zitat Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al. Body composition in French women 75+ years of age: the EPIDOS study. Mech Ageing Dev. 2003;124:311–6.PubMedCrossRef Gillette-Guyonnet S, Nourhashemi F, Andrieu S, et al. Body composition in French women 75+ years of age: the EPIDOS study. Mech Ageing Dev. 2003;124:311–6.PubMedCrossRef
12.
Zurück zum Zitat Kelly TL, Wilson KE, Heymsfield SB. Dual energy X-ray absorptiometry body composition reference values from NHANES. PLoS ONE (2009) 4:e7038. Kelly TL, Wilson KE, Heymsfield SB. Dual energy X-ray absorptiometry body composition reference values from NHANES. PLoS ONE (2009) 4:e7038.
13.
Zurück zum Zitat Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Cantet C, Grandjean H, Vellas B. Comparison of bone mineral density and body composition measurements in women obtained from two DXA instruments. Mech Ageing Dev. 2003;124:317–21.PubMedCrossRef Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Cantet C, Grandjean H, Vellas B. Comparison of bone mineral density and body composition measurements in women obtained from two DXA instruments. Mech Ageing Dev. 2003;124:317–21.PubMedCrossRef
14.
Zurück zum Zitat Folstein M, Folstein S, McHugh P. “Mini Mental State.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef Folstein M, Folstein S, McHugh P. “Mini Mental State.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef
15.
Zurück zum Zitat Grober E, Buschke H, Crystal H, et al. Screening for dementia by memory testing. Neurology. 1988;38:900–3.PubMedCrossRef Grober E, Buschke H, Crystal H, et al. Screening for dementia by memory testing. Neurology. 1988;38:900–3.PubMedCrossRef
16.
Zurück zum Zitat Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.PubMedCrossRef Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.PubMedCrossRef
17.
Zurück zum Zitat American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
18.
Zurück zum Zitat Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8.PubMedCrossRef Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8.PubMedCrossRef
19.
Zurück zum Zitat Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009; 13:708–712. Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009; 13:708–712.
20.
Zurück zum Zitat Cesari M, Pahor M, Lauretani F, et al. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci. 2009;64:377–84.PubMedCrossRef Cesari M, Pahor M, Lauretani F, et al. Skeletal muscle and mortality results from the InCHIANTI Study. J Gerontol A Biol Sci Med Sci. 2009;64:377–84.PubMedCrossRef
Metadaten
Titel
Association of a 7-year percent change in fat mass and muscle mass with subsequent cognitive dysfunction: the EPIDOS-Toulouse cohort
verfasst von
Gabor Abellan van Kan
Matteo Cesari
Sophie Gillette-Guyonnet
Charlotte Dupuy
Bruno Vellas
Yves Rolland
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cachexia, Sarcopenia and Muscle / Ausgabe 3/2013
Print ISSN: 2190-5991
Elektronische ISSN: 2190-6009
DOI
https://doi.org/10.1007/s13539-013-0112-z

Weitere Artikel der Ausgabe 3/2013

Journal of Cachexia, Sarcopenia and Muscle 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.